Investigation Launched into Align Technology Over Securities Violations

Investigation Initiated into Align Technology over Potential Securities Law Violations Robbins Geller Rudman & Dowd LLP has commenced an inquiry into possible breaches of U.S. federal securities regulations by Align Technology, Inc. (NASDAQ: ALGN). The investigation centers on whether the company's executives made false or misleading public statements or omitted crucial information that could impact investor decisions. Align Technology, renowned for its Invisalign clear aligners, iTero intraoral scanners, and exocad CAD/CAM software, recently announced its second-quarter financial results, reporting $1.01 billion in revenue—a slight decline of 1.6% compared to the previous year. The company also indicated plans to implement operational streamlining measures in the latter half of 2025 to support long-term growth and profitability. Following this disclosure, the company's stock price dropped by 37%, raising concerns among investors. Legal experts at Robbins Geller, a leading firm in securities fraud and shareholder litigation, encourage investors and potential witnesses with relevant information to get in touch. The firm has a strong track record, securing over $2.5 billion in set...